Filing Details
- Accession Number:
- 0001179110-17-005277
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-30 17:48:07
- Reporting Period:
- 2017-03-28
- Filing Date:
- 2017-03-30
- Accepted Time:
- 2017-03-30 17:48:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1358762 | Reata Pharmaceuticals Inc | RETA | Pharmaceutical Preparations (2834) | 113651945 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1551152 | Abbvie Inc. | 1 North Waukegan Road North Chicago IL 60064-6400 | No | No | Yes | No |
Transaction Summary
| Sold: | 450,000 shares | Avg. Price: $22.50 | Total Value: $10,125,000.00 |
| Number of Shares After Transactions: | 1,190,473 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2017-03-28 | 450,000 | $22.50 | 1,190,473 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
